For the past twenty years, the company has been committed to providing high-quality customized products to domestic and international customers. It has maintained stable and high-quality production, and its products are exported to nearly ten countries and regions, including the Americas, Europe, and East Asia. To cope with the rapid market expansion, accelerate the incubation of technological achievements, and expand production capacity, the company has established five major industrial bases in recent years, including Weinan Haitai, Weinan Ruilian Pharmaceutical, Pucheng Haitai, Dali Haitai, and Dali Ruilian. It has put into operation approximately 43 production lines, with about 21 more production lines under construction. The reactor vessels cover different specifications ranging from 50L to 20,000L, enabling the company to undertake production tasks for over a hundred reaction types, including Ullmann, Suzuki, Grignard, coupling, ultra-low temperature, transformation, reduction, oxidation, and more. Strict adherence to process control and equipment cleaning procedures is followed for the main production processes, including synthesis, post-treatment, column chromatography, concentration, recrystallization, hydrogenation, drying, distillation, sublimation, and more. By leveraging advanced system management platforms such as ERP and Mintab, implementing 6S on-site management and SOP operating procedures, the company ensures the stability of product quality. Management strategies such as process standardization, equipment sharing, and dedicated production lines for scaled-up products enhance overall production efficiency. As a result, the company is capable of stable production of nearly a thousand tons of products, meeting customer demands for industrialization.